Quick Takeaways
- Medytox Inc. filed SCHEDULE 13G/A for Evolus, Inc. Common stock, par value $0.00001 per share (EOLS).
- Disclosed ownership: 3.4%.
- Date of event: 31 Dec 2024.
Medytox Inc. - 31 Dec 2024 SCHEDULE 13G/A Report for Evolus, Inc. Common stock, par value $0.00001 per share (EOLS)
- Filing Manager
- Medytox Inc.
- Reporting Manager
- Medytox Inc.
- Symbol
- EOLS
- Shares outstanding
- 62,836,735 shares
- Disclosed Ownership
- 2,136,449 shares
- Ownership
- 3.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 06 Feb 2025, 16:16:23 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Medytox Inc. disclosed 3.4% ownership in Evolus, Inc. Common stock, par value $0.00001 per share (EOLS) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 06 Feb 2025, 16:16.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Medytox Inc. | 3.4% | 2,136,449 | 2,136,449 | 0 | /s/ Hyunho Jung | Hyunho Jung/CEO |